Evaluating the risks of public health programs: Rational antibiotic use and antimicrobial resistance

Annette Rid, Jasper Littmann, Alena Buyx

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Existing ethical frameworks for public health provide insufficient guidance on how to evaluate the risks of public health programs that compromise the best clinical interests of present patients for the benefit of others. Given the relevant similarity of such programs to clinical research, we suggest that insights from the long-standing debate about acceptable risk in clinical research can helpfully inform and guide the evaluation of risks posed by public health programs that compromise patients’ best clinical interests. We discuss how lessons learned regarding the ethics of risk in one context can be fruitfully transferred to the other, using the example of a so-called ‘rational antibiotic use’ guideline that limits antimicrobial prescribing in order to curb antimicrobial resistance.

Original languageEnglish
Pages (from-to)734-748
Number of pages15
JournalBioethics
Volume33
Issue number7
DOIs
StatePublished - 2019

Keywords

  • acceptable risk
  • antimicrobial resistance
  • public health ethics
  • rational use of antibiotics
  • research ethics

Fingerprint

Dive into the research topics of 'Evaluating the risks of public health programs: Rational antibiotic use and antimicrobial resistance'. Together they form a unique fingerprint.

Cite this